Samitib 400 mg Tablet

Samitib 400 mg Tablet contains imatinib mesylate 400 mg, an oral targeted anticancer medicine. It is used for certain blood cancers and gastrointestinal stromal tumors (GIST). The tablet is taken with food and water according to the treatment plan prescribed by a healthcare professional.

BUY NOW

Imatinib is a tyrosine kinase inhibitor that blocks specific proteins involved in the growth and survival of abnormal cancer cells. Samitib is used in conditions including chronic myeloid leukemia, acute lymphoblastic leukemia, GIST, and certain other specified cancers. The 400 mg presentation is available as an oral tablet, commonly supplied in a 10-tablet strip. Treatment duration and dosage depend on the condition and individual response and require regular medical monitoring.

Technical Specification

Specification Details
Active Ingredient Imatinib Mesylate
Strength 400 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 tablets
Manufacturer/Marketer Samarth Life Sciences Pvt Ltd

Product Also Known As

Samitib 400 mg Tablet, Samitib 400 Tablet, Samitib 400 mg, Samitib Imatinib Tablet, Imatinib 400 mg Tablet, Imatinib Mesylate 400 mg Tablet